[go: up one dir, main page]

CO2018002207A2 - Composiciones contra alergia a los gatos - Google Patents

Composiciones contra alergia a los gatos

Info

Publication number
CO2018002207A2
CO2018002207A2 CONC2018/0002207A CO2018002207A CO2018002207A2 CO 2018002207 A2 CO2018002207 A2 CO 2018002207A2 CO 2018002207 A CO2018002207 A CO 2018002207A CO 2018002207 A2 CO2018002207 A2 CO 2018002207A2
Authority
CO
Colombia
Prior art keywords
cat
relates
present
compositions against
compositions
Prior art date
Application number
CONC2018/0002207A
Other languages
English (en)
Inventor
Martin Bachmann
Gary Jennings
Thomas Kündig
Gabriela Senti
Franziska Zabel
Original Assignee
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Zuerich filed Critical Univ Zuerich
Publication of CO2018002207A2 publication Critical patent/CO2018002207A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

RESUMEN DE LA INVENCIÓN La presente invención se refiere al uso de una composición en un método para reducir la alergenicidad de un gato. Además, la presente invención se refiere al uso de una composición en un método para reducir la alergenicidad de un gato para un humano expuesto al gato. Además, la presente invención se refiere a composiciones que comprenden una partícula similar a virus (VLP) y al menos una proteína Fel d1. Las composiciones de la invención inducen respuestas inmunitarias eficientes, en particular respuestas de anticuerpos, en gatos y son útiles para el tratamiento y/o la prevención de la alergia a los gatos.
CONC2018/0002207A 2015-09-08 2018-02-27 Composiciones contra alergia a los gatos CO2018002207A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15184198 2015-09-08
EP15189558 2015-10-13
PCT/EP2016/071125 WO2017042241A1 (en) 2015-09-08 2016-09-07 Compositions against cat allergy

Publications (1)

Publication Number Publication Date
CO2018002207A2 true CO2018002207A2 (es) 2018-11-22

Family

ID=56997460

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2018/0002207A CO2018002207A2 (es) 2015-09-08 2018-02-27 Composiciones contra alergia a los gatos

Country Status (14)

Country Link
US (2) US10835600B2 (es)
EP (1) EP3347046B1 (es)
JP (1) JP6876682B2 (es)
KR (1) KR102812106B1 (es)
CN (1) CN108025059B (es)
AU (1) AU2016319075B2 (es)
CA (1) CA2995003A1 (es)
CO (1) CO2018002207A2 (es)
HK (1) HK1255206A1 (es)
MX (1) MX2018002926A (es)
NZ (1) NZ740816A (es)
RU (1) RU2018105007A (es)
WO (1) WO2017042241A1 (es)
ZA (1) ZA201800821B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA40824A (fr) * 2014-10-22 2017-08-29 Saiba Gmbh Particules de cmv de type virus modifié
SG11202104486VA (en) 2018-12-20 2021-05-28 Saiba AG Virus-like particles of cmv modified by fusion
KR102427400B1 (ko) 2020-09-21 2022-08-02 농업회사법인 (주)더킹콩 알러지 주요유전자 Fel d 1 타켓 고양이 셀라인 구축
CN114437211B (zh) * 2022-01-26 2024-03-12 南京麦西崴克生物科技有限公司 基于猫过敏原Fel d1的卵黄抗体的制备方法
CN114487439B (zh) * 2022-01-26 2024-12-13 南京麦西崴克生物科技有限公司 猫过敏原Fel d1卵黄抗体的间接ELISA方法
CN117004650B (zh) * 2023-06-25 2024-05-14 山东立菲生物产业有限公司 一种猫皮屑过敏原组分feld1双链二聚体重组蛋白、制备方法及应用
WO2025255685A1 (en) * 2024-06-14 2025-12-18 Angany Inc. Bioparticles for the expression of multimeric proteins
CN119409839B (zh) * 2025-01-06 2025-03-11 南京农业大学三亚研究院 一种Fel D1与Fel D4融合蛋白及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ270605A (en) * 1991-08-26 1997-07-27 Cytel Corp Cytotoxic t lymphocyte inducing peptides (6-19 amino acids) and pharmaceutical compositions thereof
WO1996021018A1 (en) * 1994-12-30 1996-07-11 Asgrow Seed Company Plants resistant to c strains of cucumber mosaic virus
WO2004042001A2 (en) * 2002-05-17 2004-05-21 Emory University Virus-like particles, methods of preparation, and immonogenic compositions
NZ538083A (en) * 2002-07-17 2006-08-31 Cytos Biotechnology Ag Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
ES2424229T3 (es) 2005-03-18 2013-09-30 Cytos Biotechnology Ag Proteínas de fusión de alérgenos de gato y utilización de las mismas
JP5484732B2 (ja) * 2005-12-14 2014-05-07 サイトス バイオテクノロジー アーゲー 過敏症の治療のための免疫賦活性核酸パッケージ粒子
CN100374152C (zh) * 2005-12-23 2008-03-12 中国农业大学 一种过敏性反应抑制剂
WO2007113633A2 (en) * 2006-04-03 2007-10-11 Pfizer Products Inc. Immunogenic compositions comprising cat allergen fel dl
JO3820B1 (ar) * 2012-05-03 2021-01-31 Regeneron Pharma أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها

Also Published As

Publication number Publication date
AU2016319075B2 (en) 2022-09-22
US10835600B2 (en) 2020-11-17
US20180250387A1 (en) 2018-09-06
WO2017042241A1 (en) 2017-03-16
JP6876682B2 (ja) 2021-05-26
NZ740816A (en) 2022-05-27
JP2018537401A (ja) 2018-12-20
AU2016319075A1 (en) 2018-04-12
CN108025059A (zh) 2018-05-11
US20210106676A1 (en) 2021-04-15
KR102812106B1 (ko) 2025-05-22
CN108025059B (zh) 2022-09-09
RU2018105007A (ru) 2019-10-10
EP3347046B1 (en) 2022-10-19
KR20180049061A (ko) 2018-05-10
ZA201800821B (en) 2018-12-19
RU2018105007A3 (es) 2020-01-31
US11571474B2 (en) 2023-02-07
MX2018002926A (es) 2019-01-30
EP3347046A1 (en) 2018-07-18
CA2995003A1 (en) 2017-03-16
HK1255206A1 (zh) 2019-08-09

Similar Documents

Publication Publication Date Title
CO2018002207A2 (es) Composiciones contra alergia a los gatos
JOP20200192A1 (ar) أجسام مضادة لـ tigit
MX2018014573A (es) Vacuna contra el virus del zika.
UY37581A (es) Compuestos para el tratamiento de la infección por virus de la hepatitis b
MX392779B (es) Anticuerpos anti-cd27
EA201692098A1 (ru) Биокерамические композиции и их применение для биомодулирования
MX2015016627A (es) Vacuna para la malaria.
MX2019015124A (es) Composicion que comprende manosa oligosacarido y proceso para realizarla y uso de esta.
BR112017007748A2 (pt) “composição farmacêutica, agente antialérgico, composição alimentar, composição cosmética, uso de um extrato, e, método para prevenir ou tratar uma doença alérgica
BR112018005905A2 (pt) ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto?
AR102547A1 (es) Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso
PE20200338A1 (es) Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil
MX2017003117A (es) Particula tipo virus de flavivirus.
PE20151588A1 (es) Vacuna contra el virus del dengue
DOP2013000149A (es) Respuesta inmune potenciada en la especie bovina.
PH12017500304A1 (en) Vaccine compositions against dengue virus diseases
CU24580B1 (es) Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas
MX381211B (es) Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia.
MY189495A (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
MX2019005102A (es) Poxvirus quimericos sinteticos.
CL2018001017A1 (es) Conservación de vitaminas hidrosolubles.
CL2018000525A1 (es) Derivados de espinosina y métodos de preparación.
BR112016024096A2 (pt) novo bacteriófago e composição compreendendo o mesmo
JO3565B1 (ar) الأجسام المضادة لشبيه الأنجيوبوييتين– 4 وطرق استخدامها
EP3256461C0 (en) UREA AND SULFONAMIDE DERIVATIVES AS HUMAN DDX3 HELICASE INHIBITORS USEFUL IN THE TREATMENT OF VIRAL DISEASES